SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Laureno R, Karp BI. Pontine and extrapontine myelinolysis following rapid correction of hyponatraemia. Lancet 1988; 72: 439440.
  • 2
    Pirzada NA, Ali I. Central pontine myelinolysis. Mayo Clin. Proc. 2001; 76: 559562.
  • 3
    Federlein T, Postert T, Muller T. Central pontine myelinolysis causes bilateral loss of deep sensitivity and pseudochoreoathetosis. J. Neurol. Neurosurg. Psychiatry 1998; 65: 607608.
  • 4
    Seiser A, Schwarz S, Aichinger-Steiner MM, Funk G, Schnider P, Brainin M. Parkinsonism and dystonia in central pontine and extrapontine myelinolysis. J. Neurol. Neurosurg. Psychiatry 1998; 65: 119121.
  • 5
    Salerno S, Kurlan R, Joy S, Shoulson I. Dystonia in central pontine myelinolysis without evidence of extrapontine myelinolysis. J. Neurol. Neurosurg. Psychiatry 1993; 56: 12211223.
  • 6
    Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain 1979; 102: 361385.
  • 7
    Vermetten E, Rutten S, Boon P, Hofman P. Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis. Gen. Hosp. Psychiatry 1999; 21: 296302.
  • 8
    Price H, Marsel-Mesulam M. Behavioural manifestations of central pontine myelinolysis. Arch. Neurol. 1987; 44: 671673.
  • 9
    Chalela J, Kattah J. Catatonia due to central pontine and extrapontine myelinolysis: Case report. J. Neurol. Neurosurg. Psychiatry 1999; 67: 692693.
  • 10
    Cummings JL. Behavioral complications of drug treatment in Parkinson's disease. J. Am. Geriatr. Soc. 1991; 39: 708716.
  • 11
    Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: Drug-induced psychiatric states. In : WeinerWJ, LangAE (eds). Behavioral Neurology of Movement Disorders: Advances in Neurology, Vol. 65. Raven Press, New York, 1995; 115138.
  • 12
    Swayze VW, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC. Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study. Biol. Psychiatry 1992; 31: 221240.
  • 13
    Tauscher-Wisniewski S, Tauscher J, Logan J, Christensen BK, Miku DJ, Zipursky RB. Caudate volume changes in first episode psychosis parallel the effects of normal ageing: A 5-year follow-up study. Schizophr. Res. 2000; 58: 185188.
  • 14
    Taylor S, Christensen JD, Holcomb JM, Garver DL. Volume increases in striatum associated with positive symptom reduction in schizophrenia: A preliminary observation. Psychiatry Res. 2005; 140: 8589.
  • 15
    Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988; 1: 179186.
  • 16
    Papapetropoulos S, Mash DC. Psychotic symptoms in Parkinson's disease. From description to etiology. J. Neurol. 2005; 252: 753764.
  • 17
    Friedman JH, Fernandez HH. Atypical antipsychotics in Parkinson-sensitive populations. J. Geriatr. Psychiatry Neurol. 2002; 15: 156170.